Synergistic composition for modulating expression of cd38
OwnerRajaram SAMANT, Manoj TONGRAinventors
Life of this patent
Estimating the term…
Abstract
The invention disclosed herein relates to synergistic composition for modulating expression of cyclic ADP ribose hydrolase (CD38). Particularly, the present invention relates to synergistic bioactive composition comprising therapeutic blend of bioactive sesquiterpenoid and at least one potent glucose uptake promoters present in specific weigh percentage along with pharmaceutically acceptable excipients. The present synergistic composition is useful in improving intracellular signaling activity, particularly the composition is used for treating upregulated cyclic ADP ribose hydrolase (CD38) disorders.
Claims10
A synergistic bioactive composition for treating upregulated cyclic ADP ribose hydrolase (CD38) disorders, wherein the composition comprising exogenous combination of;
- a) bioactive sesquiterpenoid;
- b) at least one glucose uptake promoter;
- c) at least one pharmaceutically acceptable excipients.
Dependencies are inferred from the claim text.